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ABSTRACT: The behavior of a linear copolymer of N-isopropylacrylamide with pendant vancomycin functionality was
compared to an analogous highly branched copolymer with vancomycin functionality at the chain ends. Highly branched poly(N-
isopropylacrylamide) modiﬁed with vancomycin (HB-PNIPAM-van) was synthesized by functionalization of the HB-PNIPAM,
prepared using reversible addition−fragmentation chain transfer polymerization. Linear PNIPAM with pendant vancomycin
functionality (L-PNIPAM-van) was synthesized by functionalization of poly(N-isopropylacrylamide-co-vinyl benzoic acid). HB-
PNIPAM-van aggregated S. aureus eﬀectively, whereas the L-PNIPAM-van polymer did not. It was found that when the HB-
PNIPAM-van was incubated with S. aureus the resultant phase transition provided an increase in the intensity of ﬂuorescence of a
solvatochromic dye, nile red, added to the system. In contrast, a signiﬁcantly lower increase in ﬂuorescence intensity was obtained
when L-PNIPAM-van was incubated with S. aureus. These data showed that the degree of desolvation of HB-PNIPAM-van was
much greater than the desolvation of the linear version. Using microcalorimetry, it was shown that there were no signiﬁcant
diﬀerences in the aﬃnities of the polymer ligands for D-Ala-D-Ala and therefore diﬀerences in the interactions with bacteria were
associated with changes in the probability of access of the polymer bound ligands to the D-Ala-D-Ala dipeptide. The data support
the hypothesis that generation of polymer systems that respond to cellular targets, for applications such as cell targeting,
detection of pathogens etc., requires the use of branched polymers with ligands situated at the chain ends.
■ INTRODUCTION
The development of simple to use devices for identiﬁcation of
pathogenic bacteria is an important goal in the global eﬀorts to
minimize the use of antibiotics.1−3 Early detection of pathogens
is critical in all areas of treatment of infective diseases, and
recent reviews have been published that address the following:
wound management,4 urology,5 tuberculosis,6 blood-based
infections,7 food production,8−10 and the supply of drinking
water.11 A number of approaches to such devices are possible,
and we have introduced the idea that stimulus responsive
polymers, based on poly(N-isopropylacrylamide) (PNIPAM),
could be designed to respond to the presence of bacteria.12−14
Several other possibilities are under investigation, including
DNA based biosensors,15,16 the use of ﬂuorescently labeled
lysozyme,17 antibodies fabricated into microﬂuidic devices,18
agglutination of nanoparticles,19 the use of paper based
devices,20 and the measurement of the autoﬂuorescence of
infecting bacteria.21 Another approach involves detection of
bacteria derived metabolites as they adsorb to gold nano-
particles.22 However, developing systems for the point-of care
use is diﬃcult because many of the new approaches require
laboratory-based instrumentation.23
PNIPAM is a thermally responsive polymer that has
generated considerable interest. In aqueous media, PNIPAM
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passes through a coil-to-globule transition, as chain segments
become desolvated cooperatively, at a lower critical solution
temperature (LCST).24,25 These polymers and related
copolymers have a number of potentially useful biological
applications,26−31 and recently, highly branched PNIPAM (HB-
PNIPAM) was modiﬁed in order to attach it to bacteria.12−14
HB-PNIPAM with bacteria binding end groups, targeted at
either Gram-positive or Gram-negative species, produced
aggregates of polymer and bacteria both above and below the
(nonbound) LCST. However, cooling the mixtures broke up
the aggregates. Following these observations, it was later
shown, using Förster energy transfer with labeled polymers,
that the polymers were driven through a coil-to-globule
transition on binding.32
As our work advanced in this area, a hypothesis was
developed as follows: that highly branched polymers can be
driven through a coil-to-globule transition in aqueous media
when the end groups are bound to targets but linear polymers
with pendant ligands dissociate as the ligand−target inter-
actions become shielded by the polymer in a transient globular
state. However, until now, we have not directly compared the
behavior of HB-PNIPAM with vancomycin end groups (HB-
PNIPAM-van) to analogous linear PNIPAM with pendant
vancomycin (L-PNIPAM-van).
Many studies on the adhesion of bacteria to nonfunction-
alized polymer surfaces are available usually with a view to
minimizing the adhesion of bacteria. Polymer brushes with
hydrophilic or zwitterionic polymer arms are known to
minimize adhesion.33−36 These interfaces are thought to be
nonfouling because adhesion of bacteria involves a reduction in
the entropy of the polymer arms. The same concept can be
applied to highly branched polymers, which in common with
brushes present many segments with many free chain ends to
bacteria as they interact with the interface. Therefore, one
should expect that following adsorption of bacteria to an
interface of highly branched polymers the interface would lose
entropy as the bacteria adsorbs so that adsorption would
become unfavorable. Both hydrophobicity and roughness are
also known to aﬀect the adhesion of bacteria,37 and we showed
that outer membrane protein A of Escherichia coli can have a
role as bacteria interact with various hydrogel interfaces.38
However, only a few reports are concerned with adhesion of
bacteria that is dominated by the interactions with polymer
bound ligands on surfaces.39 In addition to our work on highly
branched polymers with peptide end groups, others have
studied polymers with pendant groups that bind bacterial
lectins.36,40−42
Recently, Plenderleith et al. showed that nile red could be
used for probing the solvation state of PNIPAM with varying
degrees of branching and at varying temperatures.43 In that
work, it was shown using calorimetry that the amount of water
involved in the temperature driven desolvation (coil-to-globule
transition) was reduced as the degree of branching increased.
When nile red was dissolved in a range of solvents, the
ﬂuorescence emission spectra of nile red changed, shifting to
lower wavelength as the solvent polarity decreased. Similarly, in
aqueous solutions of the HB-PNIPAMs and nile red, the
wavelength of the maximum emission intensity decreased at the
LCST. Therefore, in this work, this dye has been used as a
ﬂuorescent probe, to investigate diﬀerences in behavior
between a HB-PNIPAM with vancomycin end groups and an
analogous linear polymer with pendant vancomycin function-
ality. Nile red (9-diethylamino-5H-benzophenoxazine-5-one) is
a solvatochromic uncharged hydrophobe, and the color and
ﬂuorescence change with the polarity of the environment. In
nonpolar solvents, it ﬂuoresces with a high quantum yield at an
emission maximum of about 530 nm, whereas the ﬂuorescence
is decreased signiﬁcantly in water.44
In this study, we used a range of techniques to compare
linear functionalized vancomycin polymer (L-PNIPAM-van) to
highly branched vancomycin polymer (HB-PNIPAM-van). For
clarity, in our work, we diﬀerentiate between branched
polymers with branches attached to single branch points
(such as combs or graft copolymers) and polymers with
branches-on-branches by referring to the latter as highly
branched polymers. The linear PNIPAM was carefully
formulated such that the polymer contained the same amount
of vancomycin and the same fraction of repeat units containing
aryl groups. This latter aspect was required because the HB-
PNIPAM contains aryl branch points and this was designed
into the linear polymer by copolymerization of NIPAM with
vinyl benzoic acid. The data reveal important diﬀerences
between the behavior of the two chemically equivalent but
architecturally diﬀerent polymers in their interactions with S.
aureus.
■ MATERIALS AND METHODS
Materials. N-Isopropylacrylamide (NIPAM) (Sigma-Aldrich, 97%)
was recrystallized three times from n-hexane/toluene (60:40). Vinyl
benzoic acid (Sigma-Aldrich, 97%) was used as received. 1,4-Dioxane
(Analarnormapur), N,N-dimethylformaldehyde (DMF) (Analarnor-
mapur), and diethyl ether (Analarnormapur) were obtained from
VWR and used as purchased. 4,4-Azobis(4-cyanovaleic acid)
(Alfaraeser, 98%), N-hydroxysuccinimide (98%), N,N-dicyclohexylcar-
bodiimide (98%), vancomycin-hydrochloride, nile red (Sigma-Aldrich,
%), toluene, and ethyl acetate were all obtained from Sigma-Aldrich
and used as received. Phosphate buﬀer tablets (pH 7.4) and dimethyl
sulfoxide (DMSO > 99.9%) were obtained from Sigma-Aldrich. Mouse
monoclonal and rabbit polyclonal antibodies to vancomycin and goat
antirabbit IgG conjugated to horse radish peroxidase (HRP) were
obtained from Abcam Plc (Cambridge, U.K.) and diluted for use as
shown below. Vinylbenzyl-pyrrolecarbodithioate (1) used as a chain
transfer agent was synthesized as previously described.43
Synthesis. Highly Branched Pyrrole/Carboxylic Acid Terminated
Polymer. HB-PNIPAM was synthesized by polymerizing N-
isopropylacrylamide (NIPAM) (5 g, 0.04419 mol) with 4-vinyl-
benzyl-1-pyrrolecarboditioate (1, RAFT agent) (0.435 g, 0.00177 mol)
in 1,4-dioxane (30 mL) at 60 °C for 48 h. 4,4-azobis(4-cyanovaleric
acid) (ACVA) (0.4704 g, 0.00177 mol) was used as an initiator in
order to obtain carboxylic acid chain ends, which are available for
further modiﬁcation. By 1H NMR, conversion of crude product was
92% before puriﬁcation. The highly branched polymers were puriﬁed
by reprecipitation three times from dioxane with diethyl ether. HB-
PNIPAM with pyrrole end groups was converted to carboxylic acid
chain ends by reacting 20 equiv of 4,4-azobis(4-cyanovaleic acid) (×3)
at 60 °C in DMF. 1H NMR (400 MHz, DMSO) (ppm): d 0.9−1.1
(6H, s, −N(CH3)2), d 1.3−1.7 (2H, br m, −CH2−CH−Ar−), d 1.8−
2.5 (2H, br m, −CH2−CH−CO−NH−) and (1H br m, CH2−CH−
CONH−), d 3.8 (1H br s, (CH3)2CH−), d 6.4 (H2, Br s, N−
pyrrole−H), d 6.6−7.6 (br, m, −Ar−), d 7.7 (2H, br s, N−pyrrole−
H). Mn = 551 kDa, Mw = 3017 kDa, Mz = 5990 kDa, Đ(w/n) = 5.47,
Đ(z/w) = 1.98.
Synthesis of HB-PNIPAM Modiﬁed with Vancomycin (HB-
PNIPAM-van). HB-PNIPAM-COOH (1 g) was dissolved in DMF
(10 cm3). N-Hydroxysuccinimide (NHS) (0.1636 g, 0.00142 mol) and
N,N-dicyclohexylcarbodiimide (DCC) (0.2930 g, 0.00142 mol) were
dissolved in DMF (5 cm3) and then added to HB-PNIPAM-COOH in
DMF solution. The reaction was conducted under an atmosphere of
nitrogen overnight. DMF was removed by rotary evaporation, and the
product was precipitated in diethyl ether. The resultant solid (HB-
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PNIPAM-succinimide) was puriﬁed by ultraﬁltration three times in
acetone:ethanol (9:1). Then, the solvent was removed by rotary
evaporation and the polymer dried under a vacuum at room
temperature. 1H NMR (400 MHz, DMSO) (ppm): d 0.9−1.1 (6H,
s, −N(CH3)2), d 1.3−1.7 (2H, br m, −CH2−CH−Ar−), d 1.8−2.5
(2H, br m, −CH2−CH−CO−NH−) and (1H br m, CH2−CH−
CONH−), d 3.8 (1H br s, (CH3)2CH−), d 6.4 (H2, Br s, N−
pyrrole−H), d 6.6−7.6 (br, m, −Ar−), d 8.0 (1H, br s, N−pyrrole−
H), d 12.0 (br m, COOH). Mn = 226 kDa, Mw = 3941 kDa, Mz = 7400
kDa, Đ(w/n) = 17.4, Đ(z/w) = 1.87.
HB-PNIPAM-succinimide (100 mg) was dissolved in deionized
water (5 cm3) over ice, and then, vancomycin (30 mg, 0.0207 mmol)
dissolved in deionized water (2 mL) and phosphate buﬀer (2 mL)
were added. The pH was adjusted with sodium hydroxide (0.1 mol
dm−3) to obtain a ﬁnal pH of 9.5. The solution was stirred over ice for
24 h, and then, the HB-PNIPAM functionalized with vancomycin was
puriﬁed by ultraﬁltration three times in deionized water. The polymer
was then freeze-dried and stored at −20 °C. 1H NMR (400 MHz,
DMSO) (ppm): d 0.9−1.1 (6H, s, −N(CH3)2), d 1.3−1.7 (2H, br m,
−CH2−CH−Ar−), d 1.8−2.2 (2H, br m, −CH2−CH−CO−NH−)
and (1H br m, CH2−CH−CONH−), d 3.9 (1H br s, (CH3)2CH−), d
6.4 (H2, Br s, N−pyrrole−H), d 6.6−7.6 (br, m, −Ar−), d 7.7 (2H, br
s, N−pyrrole−H). Mn = 2001 kDa, Mw = 6963 kDa, Mz = 10,547 kDa,
Đ(w/n) = 3.48, Đ(z/w) = 1.52.
Synthesis of Linear Poly(N-isopropylacrylamide)-co-vinyl Benzoic
Acid Functionalized P(NIPAM-co-VBA). The linear analogue of the
carboxylic acid terminated hyperbranched poly(N-isopropylacryla-
mide) was synthesized by copolymerizing NIPAM (5 g, 0.04419
mol) with vinyl benzoic acid (VBA) (0.249 g, 0.00168 mol) using 4,4-
azobis(4-cyanovaleic acid) (0.47 g, 0.00168 mol) as an initiator in 1,4-
dioxane (30 mL) at 60 °C in order to obtain the same amount of
carboxylic groups along the main chain as the highly branched
polymers. 1H NMR (400 MHz, DMSO) (ppm): d 0.9−1.1 (6H, s,
−N(CH3)2), d 1.3−1.7 (2H, br m, −CH2−CH−Ar−), d 1.8−2.2 (2H,
br m, −CH2−CH−CO−NH−) and (1H, br m, CH2−CH−
COONH−), d 3.9 (1H, br s, (CH3)2CH−), d 6.4 (H2, br s, N−
pyrrole−H), d 6.6−7.6 (br m, −Ar−), d 12.2 (br m COOH). Mn =
554 kDa, Mw = 661 kDa, Mz = 730 kDa, Đ(w/n) = 1.19, Đ(z/w) = 1.10.
Synthesis of Linear Poly(N-isopropylacrylamide)-Functionalized
with Vancomycin (L-PNIPAM-van). P(NIPAM-co-VBA) (100 mg)
was dissolved in deionized water (5 cm3) over ice, and then,
vancomycin (30 mg, 0.0207 mmol) dissolved in deionized water (2
mL) and phosphate buﬀer (2 mL) were added. The pH was adjusted
with sodium hydroxide (0.1 M) to obtain a ﬁnal pH of 9.5. The
solution was stirred over ice for 24 h, and then, the HB-PNIPAM
functionalized with vancomycin was puriﬁed by ultraﬁltration three
times in deionized water. The polymer was then freeze-dried and
stored at −20 °C. 1H NMR (400 MHz, D2O) (ppm): d 0.9−1.1 (6H,
s, −N(CH3)2), d 1.3−1.7 (2H, br m, −CH2−CH−Ar−), d 1.8−2.2
(2H, br m, −CH2−CH−CO−NH−) and (1H, br m, CH2−CH−
COONH−), d 3.9 (1H, br s, (CH3)2CH−), d 6.4 (H2, br s, N−
pyrrole−H), d 6.6−7.6 (br m, −Ar−). Mn = 637 kDa, Mw = 847 kDa,
Mz = 989 kDa, Đ(w/n) = 1.33, Đ(z/w) = 1.16.
Polymer Characterization. 1H NMR Spectroscopy. All 1H NMR
spectra were measured and recorded on a Bruker Avance 400 NMR
spectrometer running at 400 MHz.
FTIR. FT-IR measurements were carried out on a Thermo Scientiﬁc
Nicolet iS10 FT-IR spectrometer. Solid samples were dried in a
vacuum oven overnight before use.
Size Exclusion Chromatography (SEC). The average molar masses
of the polymers were determined by GPC by elution with methanol.45
Samples were dissolved at 1 mg mL−1 and injected through three
Agilent Polargel-M columns at 1 mL min−1 ﬂow rate, maintained at a
constant 30 °C. They were analyzed via comparison to a universal
calibration using PNIPAM standards via triple RI, UV, and viscometric
detection to give absolute molar mass averages and dispersity (Đw/n =
Mw/Mn and Đz/w = Mz/Mw).
Determination of LCST.
a. Micro diﬀerential scanning calorimetry (microDSC) was
conducted using a VP-DSC microcalorimeter. The lower
critical solution temperature (LCST) in polymer solution (1
mg cm−3) was deﬁned as the temperature corresponding to the
peak of the thermogram. The samples were degassed using
ThermoVac and heated and cooled from 10 to 45 °C, with a
heating rate of 0.5 °C min−1. The vancomycin modiﬁed
polymer concentration was 10 mg cm−3.
b. Turbimetry was used to measure the cloud point of polymers
using a Cary 300 bio UV−visible spectrophotometer. The
cloud point was determined at 550 nm over a range of
temperatures from 10 to 70 °C. The samples were prepared in
deionized water at a concentration of 1 mg mL−1. The heating
rate was 1 °C min−1. The onset temperature was deﬁned as the
ﬁrst stage of the onset of turbidity. In the case of vancomycin
derivative polymers, the concentration was 10 mg cm−3.
Confocal Microscopy. Bacteria−polymer complexes were viewed
by confocal microscopy using S. aureus that were labeled with the
ﬂuorescent dye, Alexa Fluoro 488 (NHS).
Fluorescence Measurements. The ﬂuorescence intensity of nile red
added to the polymer−bacteria mixtures was measured in a microplate
reader (Tecan Spectrophotometer, inﬁnite M200) using 550 nmext and
600−700 nmemm. The results were analyzed via Tecan Magellan
software.
Bacteria. For most experiments, the standard laboratory strain of S.
aureus Oxford (NCTC 6571) was used as a representative Gram-
positive, skin wound pathogen. Bacteria were maintained on brain
heart infusion agar (BHI agar), and for use, bacteria were incubated in
BHI broth at 37 °C overnight, washed, and resuspended in PBS to
obtain the desired concentration (cfu mL−1) of bacteria.
Pseudomonas aeruginosa was used as an exemplar Gram-negative
species. P. aeruginosa was prepared as described for S. aureus.
Aggregation Assay. The ability of the highly branched and linear
vancomycin-functionalized polymers to bind S. aureus and P.
aeruginosa was assessed by an aggregation assay. The bacteria were
ﬂuorescently labeled with Alexa Fluoro 488 (NHS). Alexa Fluoro 488
(NHS) dye stock solution was prepared in DMSO (1 mg cm−3) and
diluted to 1:10 in PBS before adding to bacteria (108 cfu mL−1)
resuspended in bicarbonate buﬀer, pH 8.6. Samples were dispersed at
4 °C with shaking in the dark for 1 h. Bacteria were then washed by
centrifugation exhaustively to remove unbound dye.
The resultant ﬂuorescently labeled bacteria were added to polymer
solutions (5 mg mL−1) in PBS at 37 °C in round-bottomed 96-well
plates. Plates were inspected after 2, 4, and 24 h. Separate solutions of
HB-PNIPAM-van and L-PNIPAM-van alone and suspensions of S.
aureus and P. aeruginosa alone in PBS under the same conditions acted
as controls. Samples were viewed under UV light, and parallel samples
were viewed by confocal microscopy.
Peptide Interaction. Vancomycin-functionalized polymer solution
(1 mL) in PBS (5 mg mL−1) was mixed with varying amounts of N-
acetyl-D-Ala-D-Ala peptide in PBS (1 mg mL−1 stock solution). Mixed
solutions were incubated for 10 min at room temperature before
microDSC was conducted using VP-DSC and the LCST determined
as described above.
Addition of Nile Red to Polymer Incubated with Bacteria. To
explore the solvation state of the polymers, the solvatochromic dye,
nile red, was added to polymer−bacteria mixtures. All polymer samples
and suspensions of bacteria were prepared as previously described.
However, for the incubation steps, the polymers were incubated with
S. aureus in ﬂat 96-well plates to measure ﬂuorescence intensity. After
2 h of incubation, nile red solution (0.03 mg/cm3) in PBS (100 μL)
was added directly to all samples and the ﬂuorescence intensity was
measured using a micro plate reader with Tecan Magellan software.
The excitation wavelength was 550 nm. The ﬂuorescence intensity of
samples was measured after 4 and 24 h of incubation.
Quantiﬁcation of Vancomycin in Polymers. A sandwich-enzyme-
linked immunosorbent assay (ELISA) was used to determine the
quantities of vancomycin in the highly branched and linear
functionalized polymers. Flat bottomed ELISA 96-well plates (Micro-
lon, high binding Grenier bio-one) were coated with mouse
antivancomycin monoclonal antibody diluted 1/500 in carbonate
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buﬀer pH 9.6 at 4 °C overnight. After washing with PBS-tween (0.05%
v/v tween) four times to remove unbound antibody, wells were
blocked with 3% (w/v) bovine serum albumin (BSA) in PBS for 1 h at
37 or 4 °C overnight in order to block unoccupied binding sites on the
polystyrene. Excess blocking agent was removed by washing with PBS-
tween four times, and then, polymer samples and controls (PBS blank,
HB-PNIPAM-COOH) in 1% BSA/PBS were added to wells and
incubated overnight at 4 °C. Wells were again washed four times with
PBS-tween, and rabbit antivancomycin polyclonal diluted 1/3000 in
1% BSA/PBS was added and incubated for 2 h at room temperature
followed by washing with PBS-tween four times. Finally, goat
antirabbit IgG conjugated to HRP in 1% BSA/PBS was added for 1
h at room temperature. After washing, wells were developed by the
addition of 3,3,5,5-tetramethylbenzidine substrate plus hydrogen
peroxide (30% v/v). The reaction was stopped after 25 min by
addition of 2 M H2SO4 and the resultant color measured at 450 nm.
■ RESULTS
Polymer Characterization. L-PNIPAM-van was produced
from a linear copolymer of NIPAM and VBA. The pendent
carboxylic acid groups were activated to give the NHS ester,
and then, these were modiﬁed with vancomycin. HB-PNIPAM-
van was synthesized via RAFT polymerization, and the polymer
chain ends were then modiﬁed with vancomycin. Changes in
Mw/Mn occurred during the diﬀerent stages, which reﬂect some
chain−chain coupling and the removal of low molar mass
material during ultraﬁltration. Vancomycin is an antibiotic that
binds to the peptidoglycan within Gram-positive bacteria cell
walls. The synthesis pathway for HB-PNIPAM-van followed
our previously reported route,13 and both synthesis routes are
shown in Schemes 1 and 2. The ﬁnal characterization data of
Scheme 1. Synthesis of L-PNIPAM-van
Scheme 2. Synthesis of HB-PNIPAM-van
Table 1. Characterization Data for HB-PNIPAM-van and L-PNIPAM-van
polymer Mn (kg mol
−1) Mw (kg mol
−1) Đ B-ratioa α Vancb
HB-PNIPAM-van 2001 6963 3.48 0.046 0.31 0.025
L-PNIPAM-van 637.2 847.7 1.33 0.043 0.68 0.028
aRatio of benzyl groups:NIPAM from 1H NMR. bmg mL−1 loading of Vanc (per mg of polymer).
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the vancomycin functionalized polymers are shown in Table 1
and Figure 1.
Figure 1 shows that the highly branched polymers, although
they have a much greater molar mass, exhibit similar
distributions of hydrodynamic radii to the linear polymers.
The synthesis of the linear polymer has been optimized to
achieve this result so that the eﬀect of changing polymer
architecture can be studied independently of polymer coil size.
The SEC analysis produced the molar mass averages shown
in Table 1. As shown in Figure 1, both the L-PNIPAM-van and
the HB-PNIPAM-van were high molar mass polymers (>105 g
mol−1). However, as expected, the SCVP process provided HB-
PNIPAM-van that was of higher molar mass than the L-
PNIPAM-van.
The SEC analysis allows also for the determination of α, the
exponent of the Mark−Houwink−Sakarada equation. α varies
between 0.5 (for a theta solvent) and 1 for linear polymers, and
in good solvents, α is often ≈0.7. α relates to the space
occupied by the coil. Branched polymers are more compact so
that their viscosity increases less, than linear polymers, as
concentration increases; i.e., α is depressed. Table 1 shows that
the L-PNIPAM-van had α = 0.68, and the architecture of the
HB-PNIPAM-van polymer is indicated by the much lower α =
0.31. Figure 1 also shows the chromatograms derived from the
UV (295 nm), RI, and DP (diﬀerential pressure) detectors. The
polymers contain aromatic chromophores, and the UV detector
was used to assess the distribution of these chromophores. On
the other hand, the RI detector provides a response from all
polymers regardless of the presence of a chromophore. The
data in Figure 1 show that both data sets can be superimposed,
and this indicates that the chromophores, styryl units (branch
points), and vancomycin groups were distributed evenly
throughout the molar mass distributions.
As shown in Figure 2, the 1H NMR spectra of the HB-
PNIPAM-van and L-PNIPAM-van included the usual reso-
nances for PNIPAM along with the resonances ascribable to
aryl comonomer and vancomycin units. The signals from the
hydrogen atoms of the benzene rings in the vancomycin and
the styryl comonomer units were observed at δ 6−8 ppm in
both HB-PNIPAM and L-PNIPAM.
Modiﬁcation of the chain ends and pendant functionalities to
HB-PNPAM-van and L-PNIPAM-van was investigated via
infrared spectroscopy, and the data are shown in Figure 3. The
presence of acid ends of HB-PNIPAM-COOH was conﬁrmed
by the increase, compared to the imidazole precursor, in the
peak at 1710 cm−1 obtained from CO stretching of
carboxylic chain ends. Subsequently, this peak diminished
after the succinimide/DCC reaction and new peaks at 1735,
1780, and 1800 cm−1, derived from CO antisymmetric
stretch, symmetric stretch, and carbonyl stretch, respectively,
were observed. All of these peaks were absent after the
vancomycin attachment step, showing polymer chain ends were
modiﬁed. Similarly, changes in the IR spectra were observed at
the various steps in the linear polymer.
Quantiﬁcation of the amount of vancomycin substitution in
the polymers was established using an enzyme-linked
immunosorbent assay (ELISA). The data are given in Table
1, and importantly, both polymers contained the same amount
of vancomycin.
Critical Solution Behavior. The behavior of the polymers
in solution was investigated by using microcalorimetry and
turbidimetry techniques. Both techniques can be used to
determine the LCST, but turbidimetry requires the polymer
dispersion to aggregate into structures that can scatter light.
Using microcalorimetry, the LCST was shown to increase with
each step in the derivatization process, as shown in Table 2.
The HB-PNIPAM-van and L-PNIPAM-van had similar LCSTs
of 35 and 36 °C, respectively (see Table 2).
In addition, the cloud points of all polymers were determined
by the turbidimetry technique (at 550 nm) over the
temperature range from 10 to 70 °C. The cloud point of
HB-PNIPAM-pyrrole showed an onset point of 25 °C. This
value was increased to 28 °C when the polymer was
functionalized by reaction with 4,4-azobis(4-cyanopentanoic
acid) (ACVA) to obtain acid chain ends. However, vancomycin
derivatized HB-PNIPAM-van did not provide a cloud point,
even at elevated concentration (15 mg mL−1). On the other
hand, there was a clear cloud point when the solution of L-
PNIPAM-van was heated.
Figure 1. SEC chromatograms showing data from RI, UV, and
viscometric detectors of (I) L-PNIPAM-van and (II) HB-PNIPAM-
van. (A) Molar mass distribution and (B) hydrodynamic radii
distributions of (---) L-PNIPAM-van and () HB-PNIPAM-van.
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The data for the HB-PNIPAM-van show that despite the lack
of a cloud point transition a LCST does occur, as indicated by
the microcalorimetry data. As in the previous work,12 a cloud
point was not observed for HB-PNIPAM-van in aqueous media
because the charged vancomycin groups provided electrostatic
colloidal stability to the globule and this prevented aggregation.
Assessment of Polymer Binding to Bacteria. HB-
PNIPAM-van and L-PNIPAM-van samples (5 mg mL−1) were
incubated with S. aureus (108 cfu cm−3) in PBS. The controls
were S. aureus without polymer and HB-PNIPAM-COOH
without vancomycin, and the polymers were added to a Gram-
negative species, P. aeruginosa, which should not bind
vancomycin.
After incubation for 24 h to allow bacteria to interact with
the vancomycin-functionalized polymers, the samples were
visualized by confocal microscopy and by aggregation assay.
Representative images are shown in Figure 4. The bacteria were
labeled with ﬂuorophores so that they could be observed as
bright spots in each panel. The data in Figure 4 show that the
HB-PNIPAM-van bound to S. aureus (Figure 4F) producing
aggregates. In contrast, no aggregates were seen with the L-
PNIPAM-van (Figure 4E), which appeared similar to the
controls, S. aureus in PBS without polymer (Figure 4D) or S.
aureus in HB-PNIPAM-COOH. None of the vancomycin
polymers produced aggregates with P. aeruginosa.
The images in Figure 4G−I show ﬂuorescently labeled S.
aureus in suspension with PNIPAM polymers in U-shape wells
visualized under UV light. The bacteria appear either as a
button at the bottom of the well, indicating that no aggregation
has occurred (Figure 4G and H), or as a mat covering the
bottom of the well, showing that aggregation has occurred
(Figure 4I). Aggregation occurred with the HB-PNIPAM-van,
while no aggregation occurred with the L-PNIPAM-van. Also,
no aggregation occurred with L-PNIPAM-COOH or HB-
PNIPAM-COOH which were control polymers that lacked
Figure 2. 1H NMR of (A) HB-PNIPAM-van and (B) L-PNIPAM-van.
Figure 3. FTIR spectra of HB-PNIPAM (a) and linear PNIPAM (b)
(1500−1900 cm−1) during chain end modiﬁcations (original = red,
acid modiﬁed = dashed red, succinimide modiﬁed = blue, vancomycin
modiﬁed = black).
Table 2. Summary of LCST Values of Linear and Highly
Branched Polymers and Varying End Groups Determined by
microDSC and Turbidimetry Technique
LCST (°C)
polymer types microcalorimetry turbidimetry
HB-PNIPAM 18 25
HB-PNIPAM-COOH 22 28
HB-PNIPAM-van 35 >70
L-P(NIPAM-co-VBA) 33 35
L-PNIPAM-van 36 39
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vancomycin (Figure 4J and K), showing that vancomycin was
essential for interaction with the bacteria.
Comparison of the Interactions of HB-PNIPAM-van
and L-PNIPAM-van with D-ala-D-ala Peptide. The binding
target for vancomycin is the D-Ala-D-Ala peptide,46−48 and
binding prevents cell wall synthesis in Gram-positive bacteria.
Therefore, to further investigate the interaction between
vancomycin-functionalized PNIPAMs and Gram-positive bac-
teria, we examined their interaction with the D-Ala-D-Ala
dipeptide using microcalorimetry and we sought to conﬁrm
that the vancomycin residues on the chain ends of the polymers
were still functional and able to bind this target. In designing
these experiments, we considered the hypothesis that the
energy required to pass the polymer through the coil-to-globule
transition would be lower when the peptide was bound than
when the peptide was absent. This would be so because binding
would perturb the solvation of the end groups in at least a
fraction of the polymer ensemble and this fraction would be
desolvated already at the observed LCST. The results of these
experiments are shown in Figure 5. Control polymers
(unfunctionalized HB-PNIPAM and P(NIPAM-co-VBA)) do
not undergo a decrease in the enthalpy change at the transition
on exposure to this peptide.
The data plotted in Figure 4 show the percentage enthalpy
change plotted against the relative concentration of peptide
(0−14 M dm−3) with a ﬁxed concentration of vancomycin
attached to the polymer backbone. There was a progressive
decrease in the enthalpy change when HB-PNIPAM-van was
incubated with increasing concentrations of N-acetyl-D-Ala-D-
Ala peptide. Addition of the N-acetyl-D-Ala-D-Ala peptide
resulted in less enthalpy change required for HB-PNIPAM-van
to pass from its open to its collapsed form. The enthalpy
change of HB-PNIPAM-van gradually decreased when the
peptide was added from 0.347 mM dm−3 (75 μg) to 1.74 mM
dm−3 (500 μg), but the enthalpy then decreased dramatically
above 1.73 mM dm−3 (500 μg), reaching the end point at 2.08
mM dm−3 (600 μg) of peptide. Interestingly, the same pattern
was seen with the L-PNIPAM-van; the enthalpy decreased
gradually with peptide concentrations up to 1.39 mM dm−1
(400 μg) but then suddenly decreased, reaching a plateau at
2.42 mM dm−3 (700 μg). HB-PNIPAM with pyrrole chain ends
and L-P(NIPAM-co-VBA) were used as controls and are shown
in the Supporting Information.
Figure 4. HB-PNIPAM-van and L-PNIPAM-van (5 mg mL−1) incubated with ﬂuorescently labeled bacteria (1 × 108 cfu mL−1) for 24 h. Panels A−
F show bacteria imaged by confocal microscopy, and panels G−I show aggregation assays of bacteria with polymer incubated in U-wells. P.
aeruginosa incubated in (A) PBS alone, (B) L-PNIPAM-van in PBS, and (C) HB-PNIPAM-van in PBS. S. aureus incubated in (D) PBS, (E) L-
PNIPAM-van in PBS, and (F) HB-PNIPAM-van in PBS. Aggregation assays of S. aureus (108 cfu mL−1) in (G) PBS, (H) L-PNIPAM-van in PBS, (I)
HB-PNIPAM-van in PBS, (J) L-PNIPAM-COOH, and (K) HB-PNIPAM-COOH. All were imaged under UV light. A central “button” of cells
represents no aggregation, whereas a mat indicates aggregation of bacteria (I).
Figure 5. Changes in enthalpy as the ratio of peptide:vancomycin
increased. Data shown as the fraction of the enthalpy change observed
compared to in the absence of D-Ala-D-Ala.
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These data indicated that as the polymers bound to the N-
acetyl-D-Ala-D-Ala peptide sequences hydration was disrupted
so that the amount of water involved was decreased, resulting in
less enthalpy being consumed in the desolvation process of the
polymers. Interestingly, the data showed that there was no
diﬀerence between HB-PNIPAM-van and L-PNIPAM-van in
the binding of the target peptide to the vancomycin sites
regardless of polymer architecture.
Addition of Nile Red to HB-PNIPAM-van and L-
PNIPAM-van Solutions Incubated with S. aureus. Since,
as we reported previously,12,32 the binding of bacteria to HB-
PNIPAM-van induced a phase transition from a hydrophilic
expanded state to a less solvated collapsed state, we investigated
whether a solvatochromic dye could be exploited as a reporter
of the solvation of the microenvironment of the polymers. The
adsorption or ﬂuorescence spectra of solvatochromic dyes such
as nile red changes as the polarity of the environment changes,
which can provide an indication of the solvency of the
PNIPAM segments. Samples were prepared as previously
described, and then, solutions of nile red in DMSO/PBS were
added directly to the polymer samples and incubated with
bacteria (108 cfu cm−3) at 37 °C. The ﬂuorescence intensity
was measured after 2, 4, and 24 h, and the results shown in
Figure 6 are representative of three independent experiments
performed in duplicate with the ﬂuorescence of the controls
(bacteria alone) subtracted.
These results showed that the ﬂuorescence obtained with
HB-PNIPAM-van is substantially higher than that with L-
PNIPAM-van. Also, at each time point, there was a substantial
increase in ﬂuorescence in the HB-PNIPAM-van system on
binding to S. aureus. An increase in the ﬂuorescence intensity
from the L-PNIPAM-van on mixing with S. aureus was seen, but
this was very much smaller.
Eﬀect of the Concentration of Bacteria on the
Fluorescence of Nile Red with HB-PNIPAM-van and L-
PNIPAM-van. The above data were generated using a single
concentration of bacteria. However, it is possible that each
polymer might behave diﬀerently with varying numbers of
bacteria. In this work, HB-PNIPAM-van and L-PNIPAM-van
were incubated with bacteria at 105−109 cfu cm−3 at 37 °C for 2
h. Then, nile red solutions were added into all samples and the
ﬂuorescence intensity measured (550 nm excitation). The
measurement was repeated at 4 and 24 h, and ﬂuorescence
intensities were obtained as shown in Figure 7.
From the ﬂuorescence intensity measurement of the
polymers incubated with S. aureus at diﬀerent concentrations
using nile red as a probe, it was found that at any given bacterial
load the ﬂuorescence intensity of the nile red with HB-
PNIPAM-van was much greater than that seen with the L-
PNIPAM-van. Furthermore, the ﬂuorescence intensity associ-
ated with both highly branched and linear polymers decreased
as the number of bacteria decreased (105 < 106 < 107 < 108 cfu
cm−3) at all incubation times. This suggests that the eﬀect of
decreasing the concentration of bacteria was to reduce the
amount of polymer that passed though the phase change
because fewer chain ends became bound.
■ DISCUSSION
Linear and branched polymers were prepared with similar
chemical compositions and with equivalent degrees of
vancomycin functionality. Analysis of molar mass distributions
showed that the average molar masses were higher in branched
polymers and the distributions were broader. However, it was
possible to design the linear polymer such that it had an
equivalent distribution of the hydrodynamic radii to the ﬁnal
highly branched variant. Also, SEC showed that the ultra-
ﬁltration process removed a low molar mass fraction from the
highly branched polymer. Due to the contraction of the coil as
the degree of branching increases, it is not possible to maintain
constant distributions of molar masses and hydrodynamic radii
simultaneously. However, in this work, we consider that the
important parameter that would potentially inﬂuence inter-
actions with cells and bacteria is likely to be coil size
(hydrodynamic radii) rather than molar mass.
Turbidimetry provided phase information at the macroscopic
level, and cloud points were only observed as particles
aggregated into structures that were large enough to scatter
visible light; that is, a cloud point was not observed when a
solution of HB-PNIPAM-van was heated. However, the LCST
was observed by calorimetry, which provided information on
the heat released during the dehydration process without the
necessity for aggregation to occur. On the other hand, L-
PNIPAM-van provided both an endothermic response in the
microcalorimeter and a cloud point at similar temperatures. In
Figure 6. Relative ﬂuorescent intensity of HB-PNIPAM-van and L-PNIPAM-van with nile red solution incubated alone and with 108 cfu mL−1 S.
aureus (dashed) at 37 °C for 2, 4, and 24 h. λex = 580 nm, λem = 610−680 nm.
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the case of this linear polymer with pendant ligands, the coil-to-
globule transition formed chain-folded structures in which the
polar vancomycin pendant groups were wrapped within the
globule and shielded from providing colloidal stabilization.
Therefore, the coil-to-globule transition produced aggregates
producing the cloud point. The lack of a cloud point from the
HB-PNIPAM-van was a clear example of the change in
properties observed as the polymer architecture was changed
from linear to branched while the chemical composition was
kept constant. Colloidal stability is enhanced because, in HB-
PNIPAM, the polar (vancomycin) end groups do not penetrate
the globule and remain at the surface. Thus, the HB-PNIPAM-
van globules express substantial charge; they do not aggregate,
and the globules are too small to scatter light.
The target for vancomycin is known to be the D-Ala-D-Ala
dipeptide, and binding of this to the vancomycin end groups
should perturb the solvation of the polymer. This was observed
when N-acetyl-D-Ala-D-Ala was added to HB-PNIPAM-van in
aqueous solution so that the magnitude of the endotherm at the
LCST was reduced when D-Ala-D-Ala interacted with the
vancomycin end groups. Interestingly, the eﬀect of adding D-
Ala-D-Ala was not to shift the peak of the transition. In our
view, this decrease in the magnitude of the endotherm without
a substantial change in the transition peak temperature suggests
that the binding aﬀects solvation of segments rather than the
whole polymer chain. That is, binding reduced the solvation of
chain end segments (located toward the outer regions of the
polymer coil), but the segments distant from the chain ends
remained unaﬀected. Desolvation of chain end segments on
binding N-acetyl-D-Ala-D-Ala, as shown in Figure 8A, reduced
the amount of water involved in desolvation at the coil-to-
globule transition so that the observed endotherm was reduced.
This heterogeneous desolvation is also supported by the results
from adding nile red to the system, with and without bacteria.
Nile red is a solvatochromic dye that preferentially can be
partitioned into hydrophobic phases. In the initial experimental
design, it was expected that addition of nile red to HB-
PNIPAM-van would result in a solvatochromic shift (a change
in the absorption spectrum) compared to addition of the dye to
L-PNIPAM-van. If the binding of S. aureus resulted in a coil-to-
globule transition, a large solvatochomic shift would be
observed as a more hydrophobic polymer phase was produced.
A solvatochromic shift was not observed in the presence of S.
aureus, but there was a substantial increase in ﬂuorescence
intensity (Figure 5) of the HB-PNIPAM-van that was not
observed when L-PNIPAM-van was mixed with S. aureus.
These observations are best rationalized by considering that, in
the absence of bacteria, nile red was distributed homogeneously
throughout the polymer segments, but when bacteria bind and
a fraction of the segments become desolvated, the nile red was
partitioned between the open coil (solvated) domains and the
desolvated segments. Because the system responded at the
segment length scale, a large fraction would not be aﬀected by
the change of the environment of the outer segments that were
bound to the bacteria. The calorimetric data also indicated that
a fraction of the chain segments were not aﬀected by binding so
that it is reasonable to suggest that the major fraction of the nile
red remained partitioned within open coil domains and that the
minor fraction within the desolvated domains was not suﬃcient
to produce a detectable solvatochromic shift in the adsorption
spectra. On the other hand, partitioning of the nile red into the
desolvated domains that are in close proximity to the bound
vancomycin groups can reduce the quenching of ﬂuorescence
by reducing the exposure to the solvent and adjusting its local
polarity. In our earlier work,12 we had assumed that binding
produced a general and homogeneously desolvated state, but
the current data support a modiﬁed model illustrated in Figure
8. At this point, it may be instructive to consider that the
calorimetric data indicate that both the HB-PNIPAM-van and
the L-PNIPAM-van are in critical states at the temperature in
experiments involving binding to the bacteria; i.e., the peak
temperatures are 35 and 36 °C, and the temperature of the
experiments was 37 °C. Figure 8A shows that in the nonbound
state the polymer was solvated. Changing the temperature
Figure 7. Fluorescent emission of nile red incubated with HB-
PNIPAM-van, L-PNIPAM-van, and with no polymer (controls) at 37
°C for 2, 4, and 24 h with addition of 105−108 cfu mL−1 S. aureus.
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through the LCST produced desolvation and the polymer
progressed through the coil-to-globule transition, producing an
endotherm due to the desolvation. The end groups are highly
polar, and we consider that they partially penetrate the coil
providing an osmotic pressure that swells the outer segments of
the coil below the LCST.
On binding, this osmotic driven swelling is lost as the end
groups become desolvated and are less polar. This results in
desovation of the outer segments. Thus, when the bound form
was heated and progressed though the LCST, a smaller
endotherm was observed because a smaller amount of water
was involved in solvation of the remaining segments. Figure 8B
shows how nile red would partition in this model. In the
nonbound open coil state, nile red partioned into the branched
structure and quenching of ﬂuorescence was reduced as the
close proximity of the segments provided a less polar
environment than the solvated linear polymer. Binding of the
target provided domains in which the outer segments were
desolvated, as described above, but only a fraction of the nile
red became partioned into these domains. From the data, it
appears that the majority of the nile red was not present in
these desolvated domains so that no observable shift in the
absorption spectrum was observed. However, the small fraction
that was within the desolvated domains was protected from
quenching and this gave rise to an increase in ﬂuorescence.
Figure 8. Nonhomogeneous response of HB-PNIPAM-van to binding. (A) The proposed response to binding of N-acetyl-D-Ala-D-Ala. (B) A
schematic diagram showing the response to binding to bacteria (via binding to D-Ala-D-Ala).
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The microscopy data showed that HB-PNIPAM-van bound
to these Gram-positive bacteria and formed bacteria−polymer
complexes, which then formed large aggregated structures. L-
PNIPAM-van did not bind to bacteria because at 37 °C the
pendant vancomycin groups were shielded. Binding of the
pendant vancomycin in linear polymer would be expected to
provide a desolvation, but in both the globular and open coil
forms, the pendant vancomycin groups were shielded by the
chain segments. On the other hand, in the highly branched
polymer, chain ends are predicted not to penetrate desolvated
globular structures and therefore chain end vancomycin groups
are available for interaction with the targets even in the
desolvated state. The D-Ala-D-Ala peptide sequence lies within
the peptidoglycan layer that is penetrated by lipotechoic acid
(LTA) and teichoic acid that extend to varying degrees from
the cell surface. The results reported here show that the isolated
D-Ala-D-Ala peptide binds to vancomycin attached to either L-
PNIPAM or the end groups of HB-PNIPAM. However, the
behavior of S. aureus in the presence of the two polymers was
very diﬀerent. The LTA of Gram-positive bacteria ranges in
thickness from just more than the peptidoglycan itself to
approximately 80 nm, but on average, it is around 30 nm in
thickness49 and in the case of the L-PNIPAM it seems
reasonable that shielding of the pendant vancomycin prevents
access to the D-Ala-D-Ala sequences. However, the vancoycin
groups at the chain ends of HB-PNIPAM are attached to
terminal chain segments of on average approximately 25 repeats
units. The segments will be of dimensions on the order of a few
nanometers, and we propose that segments of this length can
penetrate the LTA layer and access at least the outer regions of
the peptide glycan domain. The shielding behavior in the linear
polymers also aﬀects colloidal stability above the LCST.
Shielding behavior led to the formation of large aggregates of
the L-PNIPAM-van material above the LCST. On the other
hand, in the HB-PNIPAM-van globules, the vancomycin
provided electrostatic colloidal stability because these groups
were located at the polymer/aqueous interface. Thus, the L-
PNIPAM-van did not form aggregates with S. aureus, but the
HB-PNIPAM-van did form aggregates. Therefore, it is
suggested that cross-linking and aggregation of bacteria in the
presence of HB-PNIPAM-van is due not only to binding of
bacteria to the vancomycin groups at the chain ends but also to
the consequent phase transition, which creates a more
hydrophobic-interactive environment for the bacteria.
The diﬀerences in behavior between HB-PNIPAM-van and
L-PNIPAM-van were not evident when the isolated target for
vancomycin was bound to the polymers, and this observation
suggests that the diﬀerences in behavior in the presence of the
bacteria are due to diﬀerences in the accessibility of the
polymers to D-Ala-D-Ala in the cell wall. The evidence
presented is consistent with the hypothesis that, above the
LCST, the pendant ligands of the linear polymers became
trapped inside the collapsed polymer, rendering them
unavailable for binding to S. aureus. On the other hand, when
segments of the HB-PNIPAM-van adjacent to the vancomycin
ligands passed through the coil-to globule transition, the chain-
end vancomycin groups did not penetrate the coil and they
remained available for binding to the cellular target. The
diﬀerence in behavior was clearly not due to diﬀerences in the
degree of vancomycin substitution between the two forms of
polymer.
■ CONCLUSION
Comparison of highly branched and linear analogues of
PNIPAM with vancomycin end groups showed that polymer
architecture plays a signiﬁcant role in the performance of
functional polymers after binding to targets on bacteria. The
data indicated that placement of the ligands at the chain ends of
branched structures is required to produce polymers that
respond by passing through the coil-to-globule transition on
binding to bacteria. The data indicate that binding of bacteria
produces a phase transition on the segment length scale.
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